Biogen’s Alzheimer’s drug Aduhelm slowly gaining steam among prescribing neurologists, study findsnews2021-09-16T13:37:23+00:00September 16th, 2021|Fierce Pharma|
DNA producer Touchlight reaps $125M to expand manufacturing, fuel growthnews2021-09-16T12:42:04+00:00September 16th, 2021|Fierce Pharma|
Ready to rival J&J, Takeda’s growth plan bears fruit with FDA nod for niche lung cancer drug Exkivitynews2021-09-16T09:25:08+00:00September 16th, 2021|Fierce Pharma|
Pharma outreach to LGBTQ community lacking, reveals untapped market beyond HIV and PrEP: surveynews2021-09-15T22:11:39+00:00September 15th, 2021|Fierce Pharma|
GlaxoSmithKline’s ‘much-needed’ Shingrix rebound has yet to materialize, analysts saynews2021-09-15T20:06:45+00:00September 15th, 2021|Fierce Pharma|
As Pfizer’s booster AdComm nears, FDA staffers say COVID vaccines are already working as intendednews2021-09-15T18:29:25+00:00September 15th, 2021|Fierce Pharma|
ESMO: Facing new Keytruda combos from Merck, BMS touts 5-year kidney cancer data for Opdivo-Yervoynews2021-09-15T17:03:07+00:00September 15th, 2021|Fierce Pharma|
BeiGene’s Brukinsa turns up heat against Imbruvica with latest lymphoma nodnews2021-09-15T15:50:51+00:00September 15th, 2021|Fierce Pharma|
ALS Ice Bucket Challenge advocacy group calls for speedy FDA approval of Amylyx now-pending drugnews2021-09-15T15:28:49+00:00September 15th, 2021|Fierce Pharma|
Floating material found in Pfizer COVID-19 vaccine vials in Japan, but company says it’s not contaminationnews2021-09-15T15:20:28+00:00September 15th, 2021|Fierce Pharma|
